Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 2Diarrhea 1Breast Neoplasms 1

Interventions

Octreotide 2telotristat ethyl 1isatuximab 1ceterizine hydrochloride 1capivasertib 1cabazitaxel 1XRP6258 1Prednisone 1Loperamide 1Leucovorin 1Lapatinib 1Irinotecan 1Injections 1Granulocyte Colony-Stimulating Factor 1Fulvestrant 1Fluorouracil 1Filgrastim 1Drugs, Investigational 1Cyclophosphamide 1Colesevelam Hydrochloride 1Cell- and Tissue-Based Therapy 1Capecitabine 1Calcium Aluminosilicate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Diarrhea × Colesevelam Hydrochloride × Clear all
NCT03767257 2025-10-21

A Study of Colesevelam for Lenalidomide-Associated Diarrhea

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
25 enrolled 6 charts
Plasma cell

Diarrhea, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡